Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant topiramate in idiopathic sudden sensorineural hearing loss
TCTR20230704002Phase 2Not yet recruiting
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of topiramate in idiopathic sudden sensorineural hearing loss (ISSNHL), sponsored by Faculty of Medicine, Prince of Songkhla University. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
topiramate
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on TCTR20230704002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230704002.